@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90%.
This is in line with Shri @narendramodi Ji's vision of providing yet another vaccine to protect our children. pic.twitter.com/QUm7sZyOfi National Technical Advisory Group on Immunisation (NTAGI) on Tuesday cleared the use of SII's Covovax for Children in the age group of 12 to 17.
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12-17 age group, subject to certain conditions, on March 9.
Following this, the data of Covovax was reviewed during NTAGI meeting on April 1. It recommended that the vaccine can be included in the national COVID-19 vaccination programme for inoculating those aged 12 years and above.